Palisade Bio Inc(NASDAQ:PALI) 
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing oral therapies that target diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal (GI) tract.
Website: https://senecabio.com/
Founded: 2005
CEO: Kenneth Carter
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 4.56
H 4.56
L 4.08
C 4.29
V 38,332
10EMA 4.29
20EMA 4.29
60EMA 4.29
120EMA 4.29
250EMA 4.29